KevzaraConnect® Copay Card

Our copay card may make your copay costs more affordable*

Whether you’ve just been prescribed KEVZARA, or have already started taking it, the KevzaraConnect® Copay Card helps eligible, commercially insured patients with their copay costs for KEVZARA.

*Eligibility restrictions apply.

KEVZARAConnect copay card

With the KevzaraConnect® Copay Card, eligible patients may pay as little as a $0 copay per month.

Maximum copay assistance of $15,000 per calendar year. Subject to program terms and conditions. See Program Terms and Conditions.

Find out if you may be eligible below.

See if you may be eligible to save on prescription costs

Please tell us a little bit about yourself.


All fields required unless otherwise noted.

Do you or the person you care for have a prescription for KEVZARA?




Please select the statement that applies regarding patient's insurance coverage:




Congratulations! From the information you provided, it looks like you are eligible for a copay card!
You’re almost done. Please tell us a little more. In order to be eligible, you must be aged ≥18 years and a resident of the 50 United States, the District of Columbia, or Puerto Rico.















sharps waste disposal icon

Click here for information on Sharps Medical Waste Disposal.

A Sharps Disposal Container is used to safely and conveniently dispose of your pens or syringes.


Check the "Sign me up" box and you will be signed up for our free Sharps Mail-Back Program, which provides additional containers and mail-back boxes.


Based on the questions answered above, you are not eligible to register for a new copay card or to activate a copay card.
phone icon
KevzaraConnect® may be able to help. Patients will need to meet the eligibility criteria, including household income, to qualify. The KevzaraConnect® team can research each patient's situation and determine eligibility.

For more information, contact us at: 1-844-KEVZARA (1-844-538-9272).
Terms and Conditions

I agree to my enrollment in the KevzaraConnect® Copay Card program if confirmed as eligible, understand that copay card information will be sent to my designated specialty pharmacy/in-network specialty pharmacy along with my prescription, and any assistance with my applicable cost-sharing or co-payment for KEVZARA® (sarilumab) will be made in accordance with the Program terms and conditions.

Click to view full Terms and Conditions

I understand that I do not have to enroll in the KevzaraConnect® Copay Program or receive the Communications, and that I can still receive KEVZARA® (sarilumab) injection, as prescribed by my physician. I may opt out of receiving Communications, or opt out entirely at any time by notifying a Program representative by telephone at 1-844-KEVZARA (1-844-538-9272), Option 1, or by sending a letter to KevzaraConnect, PO Box 2914, Phoenix, AZ 85062-2914. I also understand that the services may be revised, changed, or terminated at any time.

Copay terms and conditions:

This program only applies to patients who are at least 18 years of age, residents of the 50 United States, the District of Columbia, and Puerto Rico, are prescribed KEVZARA® (sarilumab) for an FDA-approved indication, and are insured and covered by a commercial health plan. This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicaid, Medicare, VA, DOD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance program. It is not an insurance benefit, and does not cover or provide support for supplies, procedures, or any physician-related services associated with KEVZARA. General, non-product-specific insurance deductibles above the amount set forth above are also not covered. The maximum annual patient benefit under the Program is $15,000. Copay amounts after applying copay assistance may depend on the patient’s insurance plan and may vary. The Program is intended to help patients afford KEVZARA. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the Program. In those situations, the Program may change its terms. KevzaraConnect® reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms and conditions at any time without notice. Patients, pharmacists, and prescribers cannot seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this offer. This offer is not conditioned on any past, present or future purchase, including refills. The copay card is non-transferable, limited to one per person, and cannot be combined with any other offer or discount. This program is not valid where prohibited by law, taxed or restricted. Offer has no cash value. Program is not valid for cash-paying customers. Questions or concerns about deductible, copay, or coinsurance amounts or the ability to obtain KEVZARA? Contact KevzaraConnect® at 1-844-KEVZARA.

Patient Instructions: KEVZARA must be covered by your commercial insurance. Program is not valid for cash-paying customers. If your prescription is covered by insurance, you may need to notify the insurance carrier of redemption of this copay card. This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicaid, Medicare, VA, DOD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance program. This program is not valid where prohibited by law. By redeeming this coupon, you are certifying that (1) you are not a beneficiary of any government-funded program as noted above; (2) should you begin receiving prescription benefits from any government-funded program, you will withdraw from this program; and (3) you acknowledge and understand that adherence to the terms and conditions of this offer is necessary to ensure compliance with laws pertaining to any government-funded program. For questions regarding your eligibility or benefits or if you wish to discontinue your participation, please call 1-844-KEVZARA.

Pharmacist Instructions: When you use this offer, you are certifying that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other government programs for this prescription. Pharmacist will comply with his/her obligations when processing the prescription for payment. By using this offer, you agree to the terms and conditions of this program. Copay cards must be accompanied by a prescription for KEVZARA. If primary commercial prescription insurance exists, input offer information as secondary coverage and transmit using the COB segment of the NCPDP transaction. Submit transaction to RxC Acquisition Company d/b/a RxCrossroads by McKesson using BIN #610524. Applicable discounts will be displayed in the transaction response. Acceptance of this offer and your submission of claims are subject to the Terms and Conditions posted at www.mckesson.com/mprstnc. For questions regarding setup, claim transmission, patient eligibility or other issues, call the LoyaltyScript® for KEVZARA program at 1-844-KEVZARA.

BY USING THIS COPAY CARD, YOU AND YOUR PHARMACIST UNDERSTAND AND AGREE TO COMPLY WITH THESE ELIGIBILITY REQUIREMENTS AND TERMS OF USE.

Optional Marketing Consent:

By clicking “I accept” below, I authorize Sanofi US, Regeneron Pharmaceuticals, Inc., affiliates and their agents (together the “Alliance“) to contact me by mail, telephone, or email, with information about KevzaraConnect® (the “Program“), rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), products, promotions, services and research studies, and to ask my opinion about such information and topics, including market research and disease-related surveys. I further authorize the Alliance to de-identify my health information and use it in performing research including linkage with other de-identified information the Alliance receives from other sources, education, business analytics, marketing studies, or for other commercial purposes. I understand that members of the Alliance may share identifiable health information with one another in order to de-identify it for these purposes and as needed to perform the Services or to send the communications listed above (the “Communications“). I understand and agree that the Alliance may use my health information for these purposes and may share my health information with my doctors, specialty pharmacies, and insurers. I understand that I may be contacted by the Alliance in the event that I report an adverse event.



By clicking SUBMIT, I agree to the terms above.


You may have certain rights under applicable data privacy laws regarding the personal information that you provide, including the right to withdraw consent from future collection or sharing of your information. For further information regarding these rights, please reference Sanofi US Privacy Policies and Consumer Health Data Privacy Policy



Call 1-844-KEVZARA (1-844-538-9272) with any questions about the KevzaraConnect® Program or coverage.

IMPORTANT SAFETY INFORMATION

KEVZARA® (sarilumab) can cause serious side effects including:

  • SERIOUS INFECTIONS: KEVZARA is a medicine that affects your immune system. KEVZARA can lower the ability of your immune system to fight infections. Some people have had serious infections while using KEVZARA, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider should test you for TB before starting KEVZARA. Your healthcare provider should monitor you closely for signs and symptoms of TB during treatment with KEVZARA.
  • Before starting KEVZARA, tell your healthcare provider if you
    • think you have an infection or have signs or symptoms of an infection, with or without a fever such as sweats or chills, muscle aches, a cough, shortness of breath, blood in your phlegm, weight loss, warm, red, or painful skin or sores on your body, diarrhea or stomach pain, burning when you urinate or urinating more often than normal, if you feel very tired, or if you are being treated for an infection, get a lot of infections or have repeated infections.
    • have diabetes, HIV, or a weakened immune system.
    • have TB, or have been in close contact with someone with TB.
    • live or have lived, or have traveled to certain parts of the country (such as the Ohio and Mississippi River valleys and the Southwest) where there is an increased chance of getting certain fungal infections (histoplasmosis, coccidioidomycosis, or blastomycosis).
    • have or have had hepatitis.
  • After starting KEVZARA, call your healthcare provider right away if you have any symptoms of an infection.
  • CHANGES IN CERTAIN LABORATORY TEST RESULTS: Your healthcare provider should do blood tests before and after starting KEVZARA to check for low neutrophil (white blood cells that help the body fight off bacterial infections) counts, low platelet (blood cells that help with blood clotting and stop bleeding) counts, and an increase in certain liver function tests. Changes in test results are common with KEVZARA and can be severe. You may also have changes in other laboratory tests, such as your blood cholesterol levels. Your healthcare provider should do blood tests 4 to 8 weeks after starting KEVZARA and then every 6 months during treatment to check for an increase in blood cholesterol levels.
  • TEARS (PERFORATION) OF THE STOMACH OR INTESTINES: Tell your healthcare provider if you have had a condition known as diverticulitis (inflammation in parts of the large intestine) or ulcers in your stomach or intestines. Some people using KEVZARA get tears in their stomach or intestine. This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDS), corticosteroids, or methotrexate. Call your healthcare provider right away if you have fever and stomach (abdominal) pain that does not go away.
  • CANCER: KEVZARA may increase your risk of certain cancers by changing the way your immune system works. Tell your healthcare provider if you have ever had any type of cancer.
  • SERIOUS ALLERGIC REACTIONS: Serious allergic reactions can happen with KEVZARA. Get medical attention right away if you have any of the following signs: shortness of breath or trouble breathing; feeling dizzy or faint; swelling of your lips, tongue, or face; moderate or severe stomach (abdominal) pain or vomiting; or chest pain.
  • Do not use KEVZARA if you are allergic to sarilumab or any of the ingredients of KEVZARA.
  • Before using KEVZARA, tell your healthcare provider if you
    • have an infection.
    • have liver problems.
    • have had stomach (abdominal) pain or a condition known as diverticulitis (inflammation in parts of the large intestine) or ulcers in your stomach or intestines.
    • recently received or are scheduled to receive a vaccine. People who take KEVZARA should not receive live vaccines.
      • all vaccines should be brought up-to-date before starting KEVZARA, unless urgent treatment initiation is required.
    • plan to have surgery or a medical procedure.
    • are pregnant or plan to become pregnant. It is not known if KEVZARA will harm your unborn baby.
    • are breastfeeding or plan to breastfeed. Talk to your healthcare provider about the best way to feed your baby if you use KEVZARA. It is not known if KEVZARA passes into your breast milk.
    • take prescription or nonprescription medicines, vitamins, or herbal supplements. It is especially important to tell your healthcare provider if you use:
      • any other medicines to treat your RA. Using KEVZARA with these medicines may increase your risk of infection.
      • medicines that affect the way certain liver enzymes work. Ask your healthcare provider if you are not sure if your medicine is one of these.
  • The most common side effects include:
    • injection site redness
    • injection site itching
    • upper respiratory tract infection
    • urinary tract infection
    • nasal congestion, sore throat, and runny nose

These are not all the possible side effects of KEVZARA. Tell your doctor about any side effect that bothers you or does not go away. You are encouraged to report side effects of prescription drugs to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

To learn more, talk about KEVZARA with your healthcare provider or pharmacist. The FDA-approved Medication Guide and Prescribing Information can be found below or by calling 1-844-KEVZARA.

Please click here to see full Prescribing Information, including risk of SERIOUS SIDE EFFECTS, and Medication Guide.

What is KEVZARA?

KEVZARA is an injectable prescription medicine called an interleukin-6 (IL-6) receptor blocker. KEVZARA is used to treat adult patients with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a disease-modifying antirheumatic drug (DMARD) has been used and did not work well or could not be tolerated.

IMPORTANT SAFETY INFORMATION

KEVZARA® (sarilumab) can cause serious side effects including:

  • SERIOUS INFECTIONS: KEVZARA is a medicine that affects your immune system. KEVZARA can lower the ability of your immune system to fight infections. Some people have had serious infections while using KEVZARA, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider should test you for TB before starting KEVZARA. Your healthcare provider should monitor you closely for signs and symptoms of TB during treatment with KEVZARA.
  • Before starting KEVZARA, tell your healthcare provider if you
    • think you have an infection or have signs or symptoms of an infection, with or without a fever such as sweats or chills, muscle aches, a cough, shortness of breath, blood in your phlegm, weight loss, warm, red, or painful skin or sores on your body, diarrhea or stomach pain, burning when you urinate or urinating more often than normal, if you feel very tired, or if you are being treated for an infection, get a lot of infections or have repeated infections.
    • have diabetes, HIV, or a weakened immune system.
    • have TB, or have been in close contact with someone with TB.
    • live or have lived, or have traveled to certain parts of the country (such as the Ohio and Mississippi River valleys and the Southwest) where there is an increased chance of getting certain fungal infections (histoplasmosis, coccidioidomycosis, or blastomycosis).
    • have or have had hepatitis.
  • After starting KEVZARA, call your healthcare provider right away if you have any symptoms of an infection.
  • CHANGES IN CERTAIN LABORATORY TEST RESULTS: Your healthcare provider should do blood tests before and after starting KEVZARA to check for low neutrophil (white blood cells that help the body fight off bacterial infections) counts, low platelet (blood cells that help with blood clotting and stop bleeding) counts, and an increase in certain liver function tests. Changes in test results are common with KEVZARA and can be severe. You may also have changes in other laboratory tests, such as your blood cholesterol levels. Your healthcare provider should do blood tests 4 to 8 weeks after starting KEVZARA and then every 6 months during treatment to check for an increase in blood cholesterol levels.
  • TEARS (PERFORATION) OF THE STOMACH OR INTESTINES: Tell your healthcare provider if you have had a condition known as diverticulitis (inflammation in parts of the large intestine) or ulcers in your stomach or intestines. Some people using KEVZARA get tears in their stomach or intestine. This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDS), corticosteroids, or methotrexate. Call your healthcare provider right away if you have fever and stomach (abdominal) pain that does not go away.
  • CANCER: KEVZARA may increase your risk of certain cancers by changing the way your immune system works. Tell your healthcare provider if you have ever had any type of cancer.
  • SERIOUS ALLERGIC REACTIONS: Serious allergic reactions can happen with KEVZARA. Get medical attention right away if you have any of the following signs: shortness of breath or trouble breathing; feeling dizzy or faint; swelling of your lips, tongue, or face; moderate or severe stomach (abdominal) pain or vomiting; or chest pain.
  • Do not use KEVZARA if you are allergic to sarilumab or any of the ingredients of KEVZARA.
  • Before using KEVZARA, tell your healthcare provider if you
    • have an infection.
    • have liver problems.
    • have had stomach (abdominal) pain or a condition known as diverticulitis (inflammation in parts of the large intestine) or ulcers in your stomach or intestines.
    • recently received or are scheduled to receive a vaccine. People who take KEVZARA should not receive live vaccines.
      • all vaccines should be brought up-to-date before starting KEVZARA, unless urgent treatment initiation is required.
    • plan to have surgery or a medical procedure.
    • are pregnant or plan to become pregnant. It is not known if KEVZARA will harm your unborn baby.
    • are breastfeeding or plan to breastfeed. Talk to your healthcare provider about the best way to feed your baby if you use KEVZARA. It is not known if KEVZARA passes into your breast milk.
    • take prescription or nonprescription medicines, vitamins, or herbal supplements. It is especially important to tell your healthcare provider if you use:
      • any other medicines to treat your RA. Using KEVZARA with these medicines may increase your risk of infection.
      • medicines that affect the way certain liver enzymes work. Ask your healthcare provider if you are not sure if your medicine is one of these.
  • The most common side effects include:
    • injection site redness
    • injection site itching
    • upper respiratory tract infection
    • urinary tract infection
    • nasal congestion, sore throat, and runny nose

These are not all the possible side effects of KEVZARA. Tell your doctor about any side effect that bothers you or does not go away. You are encouraged to report side effects of prescription drugs to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

To learn more, talk about KEVZARA with your healthcare provider or pharmacist. The FDA-approved Medication Guide and Prescribing Information can be found below or by calling 1-844-KEVZARA.

Please click here to see full Prescribing Information, including risk of SERIOUS SIDE EFFECTS, and Medication Guide.

What is KEVZARA?

KEVZARA is an injectable prescription medicine called an interleukin-6 (IL-6) receptor blocker. KEVZARA is used to treat adult patients with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a disease-modifying antirheumatic drug (DMARD) has been used and did not work well or could not be tolerated.

The health information contained herein is provided for general educational purposes only. Your healthcare provider is the single best source of information regarding your health. Please consult your healthcare provider if you have any questions about your health or treatment.

MAT-US-2304910-v1.0-09/2024
Last Updated: October 2024